Impact of Proviral-DNA M184V/I on 96-Week Outcomes of DTG/3TC Maintenance Therapy: Results from the VOLVER Clinical Trial. (academic.oup.com)

Authors: De Lagarde M … Arribas JR Journal: Clinical Infectious Diseases Published: 2026-02-10 DOI: https://doi.org/10.1093/cid/ciag060